Multicentre Phase III Erythropoietic Protoporphyria Study

NCT04053270 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythropoietic Protoporphyria

Interventions

DRUG: Afamelanotide
DRUG: Placebo

Sponsor

Clinuvel Pharmaceuticals Limited